相关实验视频

Updated: Sep 15, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

使用全外体序列测序识别与法布里病进展相关的遗传变异

Tina Levstek¹, Bojan Vujkovac², Albina Nowak³

¹Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; Clinical Institute for Special Laboratory Diagnostics, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Molecular genetics and metabolism

|July 15, 2025

概括

研究人员确定了与法布里病进展相关的遗传变异. 一种FAT1基因变异 (rs749735949) 在法布里病患者中显著增加病衰退的风险.

科学领域:

遗传学是一个遗传学.
腎臟病學 (nephrology) 是一種醫學專業.
罕见疾病罕见疾病

背景情况:

法布里病是法布里病 (FD) 的常见并发症,临床表现各异.
影响FD脏病进展的遗传因素仍未得到充分研究.
识别预测生物标志物对于管理FD脏并发症至关重要.

研究的目的:

确定与法布里病患者病进展相关的遗传变异.
研究遗传生物标志物在预测功能衰退中的作用.
为了发现法布里脏病的潜在治疗点.

主要方法:

在300名高加索FD患者身上进行了全外组测序.
患者根据估计的淋巴细胞过率 (eGFR) 进行了分层.
生物信息分析专注于190个与细胞相关的基因的变异.

主要成果:

六种遗传变异与病进展显著相关 (FDR <0.05).
五种非编码变体显示出潜在的保护作用 (odds比率<1).
在FAT1的一个编码变体 (rs749735949) 显示,渐进性病的风险增加了14.9倍.

结论:

这种FAT1变异rs749735949可以作为FD加速eGFR下降的预测生物标志物.
这些发现突出了预防和管理法布里病的潜在目标.
进一步的研究可以利用这些遗传洞察力进行个性化治疗策略.

关键词:

费布里病是什么意思费布里病是什么意思脏 - 脏 - 脏修改变体修改变体脑细胞遗传学脑细胞遗传学腎病症是指腎病的疾病.波多细胞 (Podocytes) 是一种细胞.整体外基因组测序的测序

更多相关视频

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...